Discover ANY AI to make more online for less.

select between over 22,900 AI Tool and 17,900 AI News Posts.

<
New
Agents
Marketing
Video
Image
Music
Coding
Communication
Education
Travel
>

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.  Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss drugs,  Ozempic and Wegovy. The company promises to offer less invasive pills, instead of injectables. Its most advanced product is an oral-based GLP-1, a drug that curbs hunger.  Verdiva was founded in July 2024 by executives of Aiolos…This story continues at The Next Web

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: P

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]

Match Score: 169.02

The best smart scales for 2025
The best smart scales for 2025

<p>The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on [...]

Match Score: 137.13

Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news ro

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/f9aed8d6492d1f1dd324075bc3159326.jpg"/><p>Novo Nordisk is expanding its cash-o [...]

Match Score: 74.07

Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients
Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patient

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/9fa6a691cf1af4821a5182e3e071c7cb.jpg"/><p>Novo Nordisk (<a class="sc-1 [...]

Match Score: 70.79

Pfizer just had a big setback in its race for an Ozempic competitor
Pfizer just had a big setback in its race for an Ozempic competitor

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/5d292fcf40cc4ac2674fad7f5b5952cf.jpg"/><p>Pfizer (<a class="sc-1out364 [...]

Match Score: 67.95

Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Wegovy and Ozempic top list of 15 drugs up for next price negotiations

If the Trump admin doesn't alter the process, negotiated prices will go into effect in 2027. [...]

Match Score: 65.11

Wegovy sales took a hit this year. Novo's CEO blames off-brand competition
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/80d83acceff64c4fc5851e3ab8f802f1.jpg"/><p>Sales of Novo Nordisk’s (<a cla [...]

Match Score: 61.52

The cost of GLP-1s needs to come way down for benefits to be worth it, study says
The cost of GLP-1s needs to come way down for benefits to be worth it, stud

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/bff242956c4e53d5bab9ccff9b60df4c.jpg"/><p>While weight-loss drugs like Zepboun [...]

Match Score: 58.46

Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are d

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/5b7bde99ebf4bcf365c67209fb6357f7.jpg"/><p>Several weight loss drug stocks are [...]

Match Score: 55.74